EGFR and non-small cell lung carcinoma: Nonetheless, progress has been made towards addressing these issues, and there are emerging CAR-T cells that have shown great promise for NSCLC, such as epidermal growth factor receptor (EGFR), mesothelin (MSLN), prostate stem cell antigen (PSCA), and mucin 1 (MUC1).